CCR5-Positive Inflammatory Monocytes are Crucial for Control of Sepsis.


Journal

Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 7 2 2019
medline: 13 8 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

Neutrophils and inflammatory monocytes control sepsis by migration to the site of infection via their chemokine receptors. CCR5 is a chemokine receptor that is not expressed on neutrophils and inflammatory monocytes under homeostatic conditions. However, it has been demonstrated that CCR5 can become expressed on these cells during different models of inflammation. In the present study, we investigated if CCR5 is also expressed on neutrophil and inflammatory monocytes during sepsis, exerting an important role in the migration of these cells to the infectious focus. Using cecal ligation and puncture model to induce polymicrobial sepsis, we demonstrated that the expression of CCR5 is induced on CD11bLy6GLy6C inflammatory monocytes, but not on neutrophils (CD11bLy6GLy6C). Furthermore, CCR5 plays an important role for the migration of the inflammatory monocytes to infection focus during sepsis. CCR5-expressing inflammatory monocytes migrate from the bone marrow to the circulation and then into the site of infection, where they phagocytize and kill the bacteria. Consequently, CCR5 mice showed increased systemic inflammatory response and mortality compared to wild-type mice. These data therefore demonstrate a hitherto unrecognized protective role of CCR5 in sepsis.

Identifiants

pubmed: 30724784
doi: 10.1097/SHK.0000000000001301
doi:

Substances chimiques

CCR5 protein, mouse 0
Receptors, CCR5 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e100-e106

Auteurs

Fernanda Vargas E Silva Castanheira (FVES)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Kalil Alves de Lima (KA)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Guilherme Cesar Martelossi Cebinelli (GCM)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Fabiane Sônego (F)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Alexandre Kanashiro (A)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

David-Fernando Colon (DF)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Vanessa Borges (V)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Paula Giselle Czaikoski (PG)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

José Mauricio Mota (JM)

Cancer Institute from the State of São Paulo, University of São Paulo, São Paulo, Brazil.

Thiago Mattar Cunha (TM)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

José Carlos Alves-Filho (JC)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Foo Y Liew (FY)

Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Scotland.
School of Biology and Basic Medical Sciences, Soochow University, Suzhou, China.

Fernando Queiroz Cunha (FQ)

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
Department of CRID: Center for Research in Inflammatory Diseases, School of Medicine of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto, Brazil.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH